10
Participants
Start Date
February 10, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
March 31, 2026
Fibrinogen Concentrate Human
Refractory transfused patients who present grade ≥ 2 hemorrhagic symptoms will receive a single injection of fibrinogen concentrate (1.5g) followed by platelet transfusion within 2 hours. Blood sampling will be done at different time points to measure clot viscoelasticity: at baseline, after fibrinogen injection, after platelet transfusion and the day after transfusion or before the next platelet transfusion if \< 24 hours.
RECRUITING
CHU de Saint-Etienne, Saint-Etienne
Institut de Cancérologie de la Loire
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER